22.01.2024 09:42:50
|
EQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Heidelberg Pharma AG
/ Preliminary announcement on the disclosure of financial statements
Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Annual financial report of the group Language: German Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: July 11, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: July 11, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports
22.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Heidelberg Pharma AG |
Gregor-Mendel-Str. 22 | |
68526 Ladenburg | |
Germany | |
Internet: | www.heidelberg-pharma.com |
End of News | EQS News Service |
|
1819993 22.01.2024 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Heidelberg Pharma AGmehr Nachrichten
Analysen zu Heidelberg Pharma AGmehr Analysen
Aktien in diesem Artikel
Heidelberg Pharma AG | 2,42 | -5,47% |